↓ Skip to main content

Dove Medical Press

Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties

Overview of attention for article published in Drug Design, Development and Therapy, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
patent
3 patents

Readers on

mendeley
176 Mendeley
Title
Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties
Published in
Drug Design, Development and Therapy, October 2014
DOI 10.2147/dddt.s68872
Pubmed ID
Authors

Yan-Yang Wang, Yin-Xue Yang, Hong Zhe, Zhi-Xu He, Shu-Feng Zhou

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Italy 1 <1%
Unknown 174 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 36 20%
Student > Ph. D. Student 30 17%
Student > Bachelor 19 11%
Student > Master 11 6%
Student > Postgraduate 9 5%
Other 29 16%
Unknown 42 24%
Readers by discipline Count As %
Medicine and Dentistry 31 18%
Biochemistry, Genetics and Molecular Biology 25 14%
Agricultural and Biological Sciences 21 12%
Pharmacology, Toxicology and Pharmaceutical Science 17 10%
Chemistry 10 6%
Other 22 13%
Unknown 50 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2024.
All research outputs
#2,485,571
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#130
of 2,268 outputs
Outputs of similar age
#27,105
of 265,638 outputs
Outputs of similar age from Drug Design, Development and Therapy
#5
of 49 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.